◆ 会议时间：2023年5月31日至6月3日
◆ 会议地点：意大利 米兰

◆ 会议简介：

2023年欧洲风湿病学大会（EULAR年会）将于2023年5月31日至6月3日在意大利米兰举行，会议由欧洲抗风湿病联盟(EULAR)主办。一年一度的EULAR大会是世界风湿病学日历中的重大事件，大会将汇集来自欧洲和世界各地的医师、科学家，各年龄段的患者及其家属，卫生保健专业人士和制药行业代表；一系列多样化的EULAR活动将展示传播风湿病学领域的最新研究进展，所有活动都致力于改善风湿性骨骼肌肉疾病或受其影响的人们的健康状况。EULAR大会将再次讨论广泛的议题，包括人口、卫生服务、临床、转化和基础科学等方面的创新，致力于欧洲关节炎和风湿病患者（PARE）和风湿病卫生专业人员（HPR）的会议将成为一个突出特色！并将再次提供高质量的卫生保健行业会议，提供深入和有重点的见解。

欧洲风湿病学大会(EULAR大会)起源于2000年，现已成为欧洲交流科学和临床信息的重要平台，是全球范围内的医生、科学家、关节炎/风湿病患者、卫生专业人员和医药行业代表之间互相交流的知名论坛，EULAR大会每年6月在欧洲的一个主要城市举行，每年都有18000余名来自世界各地的代表参会，EULAR大会的科学计划涵盖了临床创新、临床、转化和基础科学宣等广泛的议题，是执业医师获取新的临床研究信息的最具创新性的平台。

欧洲抗风湿病联盟（EULAR）成立于1947年，是代表所有欧洲国家的关节炎/风湿病患者、风湿病卫生专业人员（HPR）和风湿病科学协会的非营利性科学教育协会，致力于促进、推动和支持风湿与肌肉骨骼疾病(RMDs)的研究、预防、治疗和康复。EULAR现拥有45个科学学会会员，36个PARE组织和25个卫生专业人员协会以及23个企业成员。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）。

EULAR 2023 - EULAR European Congress of Rheumatology
Date: 31 May - 03 June, 2023
Venue: Milan, Italy

Organized by： European Alliance of Associations for Rheumatology（EULAR）

Abstract submission-摘要提交

Opens：01 October 2022

Deadline：15 January 2023*

点此提交摘要>>>Submit Abstract>>>

提交指南>>Submission Guidelines>>

The regular abstract submission is free of charge.

Category and Content

Abstract submission must be in one of the different tracks:

A. Basic and translational research
B / C. Clinical topics by disease / area of research
D. Health Professionals in Rheumatology practice and clinical care research
E. Patient perspective / PARE research

The tracks are subdivided into 56 abstract topics. The correct category and topic must be selected to ensure correct scoring. The content of the abstract must be topic related.

We have introduced the use of “Keywords” in the submission process. All submitted Abstracts are mandated to select at least one and a maximum of 3 keywords in the list provided on the submission page. These “Keywords” should be related to your abstract.

Please ensure that your abstract does not contain spelling, grammatical or scientific errors, as it will be reproduced exactly as submitted. No proofreading will be done.

Submitted abstracts should only contain original data. Splitting of data originating from the same study across several abstracts and/or topics is not permitted and will lead to rejection of the abstracts.

The inclusion of trade names/brand names is NOT allowed in the abstract, including statistical programmes or other, unless this is peculiar and adds value to their work. The mentioning of agents/molecules must follow the scientific standard for publications.

Format and Length

• For clinical abstract submissions, the presenting author can be any of the listed authors without affiliations to industry. For basic, translational and clinical studies below Phase 2, the presenting author can be any of the listed authors.
   
• Conflict of interest: It is the intent of EULAR to provide high quality sessions focused on educational content that is free from commercial influence or bias. Thus, the submitting author of an abstract is requested to declare any potential conflicts of interest for all authors during the abstracts' submission.

• It is mandatory to use the abstract word template provided by the system. Please read all instructions carefully before preparing your abstract. We recommend limiting your abstract to 55 lines.
• Counting towards the 3600 characters:
  • Abstract title (minimum 15, maximum 300 characters)
  • Headings and content of the abstract word template, structured into the following sections:

a. Background:
b. Objectives:
c. Methods:
d. Results:
e. Conclusions:
f. References:
g. Characters from table content including title and footnotes.

• Characters not counted, but part of final abstract:

— Author first names, middle initials and last names
— Author affiliations
— Acknowledgements including working group
— Working group + "on behalf of" if entered
— Abstract number
— DOI (Declaration of conflict of interest)
— Invisible characters such as spaces

• Tables (characters included count): A maximum of 1 table can be included in the abstract word template with the following criteria: Combined maximum number of columns: 12 / rows: 20
• Graphs / Images: A maximum of 1 graph or 1 image each can be included. Tables turned into pictures/images are not accepted.
• Abstracts can be re-edited and modified until the submission deadline

Dear Friends,

Since its foundation in 1947, the European Alliance of Associations for Rheumatology, EULAR, has been recognised in the wide-ranging spectrum of World Rheumatology as a prestigious and reputable non-profit organisation with the highest profile on the continent. Among the multitude of outstanding EULAR activities, the EULAR European Congress of Rheumatology represents the flagship of our organisation, every year providing the utmost rheumatology congress experience. 

The EULAR Congress is comprised of an extensive network of innovative minds working towards illustrating the latest scientific breakthroughs in clinical, translational, and basic sciences, discussing what is new in dedicated sessions, presenting data on how to treat rheumatic and musculoskeletal diseases (RMDs), giving view to the transfer of results from bench to bedside, showing the practical aspects of our specialty in specific workshop discussions, offering debates, and, in essence, displaying the future of Rheumatology. 

2022 was an extraordinary year for EULAR, as we held our first-ever hybrid Congress in Copenhagen and marked our 75th anniversary! Thanks to the great flexibility of the EULAR Rheumatology Community and its high capacity to rapidly adapt to the ever-evolving challenges faced in the pandemic era, EULAR prevailed with this new and highly innovative congress structure, attracting a total of more than 14,000 participants onsite and virtually.  

EULAR recognises the pivotal role face-to-face interactions play for our doctors, delegates, and patients, and we appreciate the importance, value, and benefits of an onsite congress experience. Therefore, we are excited to announce that in 2023 we are shifting to our original onsite-only congress experience, with on-demand access available after the live congress days.  

The EULAR 2023 Congress will take place in one of the most beautiful and vibrant cities in Europe – Milan! We look forward to returning to a city that acknowledges our organisation and supports its three pillars and communities, aiming to reduce the impact of RMDs on those afflicted and improve their social position and quality of life. We look forward to sharing our new strategy for 2024 - 2028, recent developments in Rheumatology, scientific sessions, abstracts, and more. 

I am extremely proud of EULAR’s achievements thus far, and I would like to thank all members of the EULAR Family, the EULAR Office, and the faculty of the EULAR 2023 Congress for their commitment to this new experience. And my special thanks to the numerous delegates who will attend our marvellous congress in 2023. 

I am looking forward to meeting you all onsite, in Milan, on 31 May – 03 June, 2023. 

My warmest regards,

Annamaria Iagnocco
EULAR President

EULAR2023 注册费：

Please note that entrance to the onsite congress might be subject to presenting a COVID certificate and/or other documents as required.

Access rights to the EULAR ONSITE CONGRESS and other benefits

For all participants

Access to the scientific and abstract sessions onsite 31 May 2023 – 3 June 2023 and on demand content as of Monday 5 June 2023 until 31 July 2023, 23.59 CEST.

Additionally for Ordinary Delegates/Ordinary Trainees

Access to all satellite symposia, consult the expert events and industry exhibition onsite 31 May 2023 – 3 June 2023 and on demand content as of Monday 5 June 2023 until 31 July 2023, 23.59 CEST.

Additionally for Company Representative "pharma"

Access to all satellite symposia, consult the expert events and industry exhibition onsite 31 May 2023 – 3 June 2023 and on demand content as of Monday 5 June 2023 until 31 July 2023, 23.59 CEST.

◆ 参会对象：医师、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。